Authors
Loading...
Preclinical study demonstrates that oxidized mitochondrial DNA activates TLR9 to drive NLRP3 inflammasome-mediated cell death in myelodysplastic syndromes, highlighting a potential therapeutic target.
Ward et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: